Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Hemab Therapeutics Holdings, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
SPRUCE BIOSCIENCES, INC.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Apellis Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Apellis Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Apellis Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Apellis Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Apellis Pharmaceuticals, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Apellis Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Apellis Pharmaceuticals, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Apellis Pharmaceuticals, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
SPRUCE BIOSCIENCES, INC.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Apellis Pharmaceuticals, Inc.Listing unverified | AwardD (derivative) | $507.8K | SEC | ||
Apellis Pharmaceuticals, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |